Psychedelics
Behind the World-First Export of Jamaican Psilocybin Mushrooms
The biotech and life sciences company Mydecine Innovations Group recently announced it had completed its first commercial export of legal psychedelic psilocybin mushrooms from Jamaica to Canada. Technology Networks caught up with the company's chief scientific officer, Rob Roscow, to find out more.
MDMA-assisted Therapy a “Promising New Treatment” for PTSD, Finds Review
The researchers found MDMA-assisted psychotherapy to have a particularly “impressive effect size” in reducing PTSD symptoms. But they say more studies will be needed before the drug can be recommended for clinical practice.
Canadian Cannabis Lab Gets Approval to Study Psilocybin
The team at Complex Biotech Discovery Ventures, based in Vancouver, intend to expand the current knowledge base for the psilocybin mushrooms and create a compound library describing the major and minor chemical constituents that make up these mushrooms.
How Cannabis Interacts With Psychedelics
As progressive reform slowly arrives to cannabis and psychedelics possession, attention will inevitably be given to how the substances can interact. So, what do we already know?
A Brief History of Psychedelic Research With Albert Garcia-Romeu
Albert Garcia-Romeu, an assistant professor at the Center for Psychedelic and Consciousness Research at Johns Hopkins University, walks Analytical Cannabis through the past, present, and future of psychedelic research.
Making Mushrooms: How Psilocybin Is Extracted and Used in Mental Health Research
Psilocybin’s emergence as a valuable tool for mental health research has been a huge breakthrough for the field. But how do researchers get their hands on this heavily regulated substance? We talked to Tim Moore, CEO of Havn Life Sciences, a company that produces psychoactive compounds from plants and fungi, to find out more.
Could DMT-Assisted Therapy Help Treat Mental Health Disorders?
The role that psychedelic therapeutics could play in tackling many intractable mental health conditions has finally been recognized by mainstream medicine. To find out more, we spoke to Carol Routledge, chief medical and scientific officer at Small Pharma.
Oregon Becomes First US State to Decriminalize Drug Possession and Legalize Psilocybin Therapy
In a historic US first, Oregon voters have approved a ballot measure that will decriminalize the personal possession of all currently illegal drugs, including cocaine, heroin, and methamphetamine.
The Startup Turning Yeast Into Psychedelics
We spoke with Nick Milne, co-founder and CSO at Octarine to learn more about what science says on the therapeutic benefits of psychedelic compounds, why a bio-based approach for manufacturing is advantageous and the challenges associated.
